Okuyama T, Ishiura S, Nojima M, Tsukahara T, Yanagida M, Sugita H
Department of Obstetrics and Gynecology, Tokyo Metropolitan Tsukiji Maternity Hospital, Japan.
Clin Chim Acta. 1991 Feb 15;196(2-3):207-15. doi: 10.1016/0009-8981(91)90074-m.
The activities of serum aminopeptidases (APs) derived from the placenta rise during pregnancy. To confirm the localization of AP-A, which liberates N-terminal acidic amino acids, in placental tissue and to identify it in the serum of pregnant women, chromatographic separation was performed. When a placental extract was subjected to DEAE cellulose column chromatography, the Glu-MCA degradative activity, or AP-A, was separated into two entities. Inhibition testing revealed that the enzyme eluted in Fraction No. 20 from the DEAE-cellulose column consisted of typical AP-A with a molecular weight of approximately 500,000. When the Glu-MCA degradative activity was observed by filtering pregnant serum through HPLC TSK G3000 gel, the activity was found to be due to serum CAP rather than AP-A. What had been thought to be a biochemicophysiological action inherent in blood AP-A raised additional questions.
胎盘来源的血清氨基肽酶(APs)活性在孕期升高。为了确定可释放N端酸性氨基酸的AP-A在胎盘组织中的定位,并在孕妇血清中鉴定该酶,进行了色谱分离。当胎盘提取物进行DEAE纤维素柱色谱分析时,Glu-MCA降解活性或AP-A被分离为两个实体。抑制试验表明,从DEAE纤维素柱第20部分洗脱的酶由分子量约为500,000的典型AP-A组成。当通过HPLC TSK G3000凝胶过滤孕妇血清观察Glu-MCA降解活性时,发现该活性归因于血清CAP而非AP-A。过去被认为是血液AP-A固有的生物化学物理作用引发了更多问题。